Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults

Vaccine

Volumn 30, Issue 5, 2012, Pages 879-885

  Hakim, Hana ^a   Allison, Kim J ^a   Van De Velde, Lee Ann ^a   Li, Yimei ^a   Flynn, Patricia M ^a   McCullers, Jonathan A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

H1N1; Immunocompromised; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILL; COUGHING; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; HEADACHE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; INFANT; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MYALGIA; NEOPLASM; NOSE CONGESTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RHINORRHEA; SCHOOL CHILD; SEROCONVERSION; SICKLE CELL ANEMIA; SIDE EFFECT; SORE THROAT; VIRUS LOAD; VIRUS NEUTRALIZATION; VOMITING;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; NEOPLASMS; NEUTRALIZATION TESTS; PROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 84855453134     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.105     Document Type: Article

References (52)

1. Elting L.S., Whimbey E., Lo W., Couch R., Andreeff M., Bodey G.P. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer 1995, 3(May (3)):198-202.
2. Feldman S., Webster R.G., Sugg M. Influenza in children and young adults with cancer: 20 cases. Cancer 1977, 39(January (1)):350-353.
3. Gooskens J., Jonges M., Claas E.C., Meijer A., Kroes A.C. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009, 199(May 15 (10)):1435-1441.
4. Kempe A., Hall C.B., MacDonald N.E., Foye H.R., Woodin K.A., Cohen H.J., et al. Influenza in children with cancer. J Pediatr 1989, 115(July (1)):33-39.
5. Kunisaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009, 9(August (8)):493-504.
6. Leekha S., Zitterkopf N.L., Espy M.J., Smith T.F., Thompson R.L., Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007, 28(September (9)):1071-1076.
7. Ljungman P., Andersson J., Aschan J., Barkholt L., Ehrnst A., Johansson M., et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993, 17(August (2)):244-247.
8. Madhi S.A., Ramasamy N., Bessellar T.G., Saloojee H., Klugman K.P. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J 2002, 21(April (4)):291-297.
9. Madhi S.A., Schoub B., Simmank K., Blackburn N., Klugman K.P. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr 2000, 137(July (1)):78-84.
10. Sato M., Hosoya M., Kato K., Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005, 24(October (10)):931-932.
11. Whimbey E., Elting L.S., Couch R.B., Lo W., Williams L., Champlin R.E., et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994, 13(April (4)):437-440.
12. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59(August 6 (RR-8)):1-62.
13. Loulergue P., Mir O., Alexandre J., Ropert S., Goldwasser F., Launay O. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol 2008, 19(September (9)):1658.
14. Porter C.C., Poehling K.A., Hamilton R., Frangoul H., Cooper W.O. Influenza immunization practices among pediatric oncologists. J Pediatr Hematol Oncol 2003, 25(February (2)):134-138.
15. Bektas O., Karadeniz C., Oguz A., Berberoglu S., Yilmaz N., Citak C. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Pediatr Blood Cancer 2007, 49(December (7)):914-917.
16. Chisholm J., Howe K., Taj M., Zambon M. Influenza immunisation in children with solid tumours. Eur J Cancer 2005, 41(October (15)):2280-2287.
17. Chisholm J.C., Devine T., Charlett A., Pinkerton C.R., Zambon M. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001, 84(June (6)):496-500.
18. Porter C.C., Edwards K.M., Zhu Y., Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2004, 42(January (1)):36-40.
19. Reilly A., Kersun L.S., McDonald K., Weinberg A., Jawad A.F., Sullivan K.E. The efficacy of influenza vaccination in a pediatric oncology population. J Pediatr Hematol Oncol 2010, 32(July (5)):e177-e181.
20. Shahgholi E., Ehsani M.A., Salamati P., Maysamie A., Sotoudeh K., Mokhtariazad T. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatr Blood Cancer 2010, 54(May (5)):716-720.
21. Goossen G.M., Kremer L.C., van de Wetering M.D. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev 2009, (2):CD006484.
22. Matsuzaki A., Suminoe A., Koga Y., Kinukawa N., Kusuhara K., Hara T. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer 2005, 45(November (6)):831-837.
23. Hsieh Y.C., Lu M.Y., Kao C.L., Chiang B.L., Lin D.T., Lin K.S., et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy. J Formos Med Assoc 2002, 101(October (10)):700-704.
24. Gross P.A., Lee H., Wolff J.A., Hall C.B., Minnefore A.B., Lazicki M.E. Influenza immunization in immunosuppressed children. J Pediatr 1978, 92(January (1)):30-35.
25. Steinherz P.G., Brown A.E., Gross P.A., Braun D., Ghavimi F., Wollner N., et al. Influenza immunization of children with neoplastic diseases. Cancer 1980, 45(February 15 (4)):750-756.
26. Amendola A., Boschini A., Colzani D., Anselmi G., Oltolina A., Zucconi R., et al. Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users. J Med Virol 2001, 65(December (4)):644-648.
27. Iorio A.M., Alatri A., Francisci D., Preziosi R., Neri M., Donatelli I., et al. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. Vaccine 1997, 15(January (1)):97-102.
28. Kroon F.P., Rimmelzwaan G.F., Roos M.T., Osterhaus A.D., Hamann D., Miedema F., et al. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 1998, 12(December 3 (17)):F217-F223.
29. Madhi S.A., Maskew M., Koen A., Kuwanda L., Besselaar T.G., Naidoo D., et al. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis 2011, 52(January 1 (1)):128-137.
30. Miotti P.G., Nelson K.E., Dallabetta G.A., Farzadegan H., Margolick J., Clements M.L. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989, 262(August 11 (6)):779-783.
31. Torii Y., Kimura H., Ochi N., Kaneko K., Ando H., Kiuchi T., et al. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Vaccine 2011, 29(Jun 6 (25)):4187-4189.
32. Yen T.Y., Jou S.T., Yang Y.L., Chang H.H., Lu M.Y., Lin D.T., et al. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer. Pediatr Blood Cancer 2011, 57(Dec 15 (7)):1154-1158.
33. Crum-Cianflone N.F., Eberly L.E., Duplessis C., Maguire J., Ganesan A., Faix D., et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis 2011, 52(January 1 (1)):138-146.
34. Crum-Cianflone N.F., Iverson E., Defang G., Blair P.J., Eberly L.E., Maguire J., et al. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine 2011, 29(April 12 (17)):3183-3191.
35. Tebas P., Frank I., Lewis M., Quinn J., Zifchak L., Thomas A., et al. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 2010, 24(September 10 (14)):2187-2192.
36. Allison J.E., Glezen W.P., Taber L.H., Paredes A., Webster R.G. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. J Infect Dis 1977, 136(December (Suppl.)):S672-S676.
37. McCullers J.A., Van De Velde L.A., Allison K.J., Branum K.C., Webby R.J., Flynn P.M. Recipients of vaccine against the 1976 swine flu have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis 2010, 50(June 1 (11)):1487-1492.
38. Ganz P.A., Shanley J.D., Cherry J.D. Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978, 42(November (5)):2244-2247.
39. Lange B., Shapiro S.A., Waldman M.T., Proctor E., Arbeter A. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. J Infect Dis 1979, 140(September (3)):402-406.
40. Smithson W.A., Siem R.A., Ritts R.E., Gilchrist G.S., Burgert E.O., Ilstrup D.M., et al. Response to influenza virus vaccine in children receiving chemotherapy for malignancy. J Pediatr 1978, 93(October (4)):632-634.
41. Sumaya C.V., Williams T.E., Brunell P.A. Bivalent influenza vaccine in children with cancer. J Infect Dis 1977, 136(December (Suppl.)):S656-S660.
42. Brydak L.B., Rokicka-Milewska R., Machala M., Jackowska T., Sikorska-Fic B. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr Infect Dis J 1998, 17(February (2)):125-129.
43. Brown A.E., Steinherz P.G., Miller D.R., Armstrong D., Kellick M.G., Gross P.A., et al. Immunization against influenza in children with cancer: results of a three-dose trial. J Infect Dis 1982, 145(January (1)):126.
44. Stiver H.G., Weinerman B.H. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Can Med Assoc J 1978, 119(October 7 (7)):733-735. 738.
45. Shildt R.A., Luedke D.W., Kasai G., El-Beheri S., Laham M.N. Antibody response to influenza immunization in adult patients with malignant disease. Cancer 1979, 44(November (5)):1629-1635.
46. Ortbals D.W., Liebhaber H., Presant C.A., Van Amburg A.L., Lee J.Y. Influenza immunization of adult patients with malignant diseases. Ann Intern Med 1977, 87(November (5)):552-557.
47. Brydak L.B., Calbecka M. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leuk Lymphoma 1999, 32(January (3-4)):369-374.
48. Glezen W.P., Glezen L.S., Alcorn R. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Child 1983, 137(November (11)):1095-1097.
49. Souza A.R., Braga J.A., de Paiva T.M., Loggetto S.R., Azevedo R.S., Weckx L.Y. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Vaccine 2010, 28(January 22 (4)):1117-1120.
50. Huber V.C., McKeon R.M., Brackin M.N., Miller L.A., Keating R., Brown S.A., et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 2006, 13(September (9)):981-990.
51. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(Nov 12 (20)):1945-1952.
52. Tremblay C.L., Rouleau D., Fortin C., Toma E., Sylla M., Cyr L., et al. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine 2011, 29(February 4 (7)):1359-1363.